tobramycin treatment pseudomona aeruginosa infect cystic fibrosi tobramycin treatment chronic pulmonari infect caus pseudomona aeruginosa 13 children cystic fibrosi evalu initi patient receiv recommend dose 125 mgm224 hour dose increas 250 mgm224 hour approxim 10 mgkg24 hour higher dosag administ intramuscularli 9 patient eight receiv addit therapi aerosol contain tobramycin therapi possibl erad ps aeruginosa respiratori tract 5 patient discontinu therapi ps aeruginosa reoccur patient within one month patient show clinic improv relat therapi toxic allerg side effect observ